Managing Depression for Residents in Nursing Facilities
DATA SOURCES: Articles indexed in PubMed for the last 20 years, American Psychiatric Association Guidelines, CMS Interpretive Guidelines from the SOM, and The American Medical Directors Association (AMDA) Guidelines.
STUDY SELECTION AND DATA EXTRACTION: Forty published papers were reviewed, and criteria supporting the primary objective were used to identify useful resources.
DATA SYNTHESIS: The literature included guidelines regarding the management of late-life depression (e.g., dosage and duration of therapy). This literature was examined in relation to the current CMS Interpretive Guidelines, which are provided to state surveyors to help them evaluate whether a nursing facility is in compliance with federal regulations. These guidelines provide explanation and clarification of the actual regulations and so are used during evaluation of the facility.
CONCLUSION: Current recommendations indicate that a first episode of depression should be treated for 12 months beyond full remission, according to AMDA guidelines. Longer treatment durations (maintenance phase) are needed depending on the resident's situation (e.g., severity or number of episodes). In addition, evidence suggests that antidepressants should remain at the same dose through the maintenance phase of treatment. The Interpretive Guidelines require a dosage reduction to the lowest effective dose by decreasing the dose two times in the first year unless “clinically contraindicated to discontinuation” is documented. This correlates to a dosage reduction within the first nine months of antidepressant treatment. This necessitates that in the majority of depressive episodes, clinicians document their rationale for continuing treatment. Clinicians must commit to this process, and surveyors must acknowledge this appropriate approach to depression management.
Keywords: ACNP = American College of Neuropsychopharmacology; AMDA = American Medical Directors Association; APA = American Psychiatric Association; Antidepressants; CAD = Coronary artery disease; CMS = Centers for Medicare & Medicaid Service; Centers for Medicare & Medicaid Services; DSM-IV-TR = Diagnostic and Statistical Manual, Fourth Edition, Text Revision; Depression; Dose; Duration; EC = Enteric coated; Elderly; GDR = Gradual dosage reductions; Interpretive Guidelines State Operations Manual Operational Guidelines; PHQ-9 = Patient Health Questionnaire; SOM = State Operations Manual
Document Type: Research Article
Publication date: 2012-07-01
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites